217 related articles for article (PubMed ID: 12772500)
1. Antisense oligonucleotide therapy in cancer.
Stephens AC; Rivers RP
Curr Opin Mol Ther; 2003 Apr; 5(2):118-22. PubMed ID: 12772500
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 family members as molecular targets in cancer therapy.
Marzo I; Naval J
Biochem Pharmacol; 2008 Oct; 76(8):939-46. PubMed ID: 18638457
[TBL] [Abstract][Full Text] [Related]
3. The future of antisense therapy: combination with anticancer treatments.
Biroccio A; Leonetti C; Zupi G
Oncogene; 2003 Sep; 22(42):6579-88. PubMed ID: 14528283
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential.
Olie RA; Zangemeister-Wittke U
Drug Resist Updat; 2001 Feb; 4(1):9-15. PubMed ID: 11512155
[TBL] [Abstract][Full Text] [Related]
6. The role of antisense oligonucleotides in the treatment of bladder cancer.
Duggan BJ; Gray S; Johnston SR; Williamson K; Miyaki H; Gleave M
Urol Res; 2002 Jul; 30(3):137-47. PubMed ID: 12111175
[TBL] [Abstract][Full Text] [Related]
7. Toxicology of antisense therapeutics.
Jason TL; Koropatnick J; Berg RW
Toxicol Appl Pharmacol; 2004 Nov; 201(1):66-83. PubMed ID: 15519609
[TBL] [Abstract][Full Text] [Related]
8. Potential roles of antisense therapy in the molecular targeting of genes involved in cancer (review).
Kim R; Tanabe K; Emi M; Uchida Y; Toge T
Int J Oncol; 2004 Jan; 24(1):5-17. PubMed ID: 14654935
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis, Bcl-2 antisense, and cancer therapy.
Piro LD
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 10):5-10. PubMed ID: 15651171
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide therapy in urology.
Kausch I; Böhle A
J Urol; 2002 Jul; 168(1):239-47. PubMed ID: 12050550
[TBL] [Abstract][Full Text] [Related]
11. Antisense therapy for cancer.
Gleave ME; Monia BP
Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of angiogenesis by antisense oligonucleotides to clusterin.
Jackson JK; Gleave ME; Gleave J; Burt HM
Angiogenesis; 2005; 8(3):229-38. PubMed ID: 16308731
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
Kim R; Emi M; Tanabe K; Toge T
Cancer; 2004 Dec; 101(11):2491-502. PubMed ID: 15503311
[TBL] [Abstract][Full Text] [Related]
14. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
Kausch I; Böhle A
Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
[TBL] [Abstract][Full Text] [Related]
15. Antisense therapy for cancer--the time of truth.
Jansen B; Zangemeister-Wittke U
Lancet Oncol; 2002 Nov; 3(11):672-83. PubMed ID: 12424069
[TBL] [Abstract][Full Text] [Related]
16. Response of bladder carcinoma cells to TRAIL and antisense oligonucleotide, Bcl-2 or clusterin treatments.
Sun B; Moibi JA; Mak A; Xiao Z; Roa W; Moore RB
J Urol; 2009 Mar; 181(3):1361-71. PubMed ID: 19157446
[TBL] [Abstract][Full Text] [Related]
17. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
Oberbauer R
Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
[TBL] [Abstract][Full Text] [Related]
18. Nucleic-acid therapeutics: basic principles and recent applications.
Opalinska JB; Gewirtz AM
Nat Rev Drug Discov; 2002 Jul; 1(7):503-14. PubMed ID: 12120257
[TBL] [Abstract][Full Text] [Related]
19. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent.
Chen T; Turner J; McCarthy S; Scaltriti M; Bettuzzi S; Yeatman TJ
Cancer Res; 2004 Oct; 64(20):7412-9. PubMed ID: 15492264
[TBL] [Abstract][Full Text] [Related]
20. Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy.
Kim R; Emi M; Matsuura K; Tanabe K
Cancer Gene Ther; 2007 Jan; 14(1):1-11. PubMed ID: 17041564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]